Trial · NCT07085806
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To assess effect of Pentoxifylline supplementation on Anatomical (Volume) Regeneration of liver in the Perioperative period (POD-14) in Right lobe donor Hepatectomy | 2 weeks post-operatively | Regenerated liver volume post-surgery Day-14 and Percentage of volume restored after Post surgery day 14 as compared to pre-operatively calculated Remnaant liver volume |
| Secondary | To evaluate the effect of Pentoxifylline on Serum Bilirubin- Time to Normalization | 2 weeks | Serum bilirubin on Post-operative Day 1 to 7 and 14 |
| Secondary | To evaluate the effect on HGF | 1 week | HGF (Hepatocyte Growth Factor) levels on Baseline, Postoperative Day 3, and Day 7 |
| Secondary | To study the effect of Pentoxifylline supplementation on post-operative complications in donor right hepatectomy | Postoperative Day 14 | Clavien-Dindo Classification Grading on Post-operative Day 14 |
| Secondary | Time to normalziation of Aspartate Transaminase | Post-operative Day 14 | Aspartate transaminase (Baseline, Post-operative Day 1 to 7 and 14) |
| Secondary | Time to normalzation of Alanine transaminase | Post-operative Day 14 | Alanine Transaminase on BASELINE, POST-OPERATIVE DAY 1 TO 7 and 14 |
| Secondary | Time to Normalisation of International Normalized Ratio | Post-operative Day 14 | International Normalized Ratio on Baseline Post-operative Day 1 to 7 and 14 |
| Secondary | Time to normalisation of Serum Alkaline phosphatase | Post-operative Day 14 | Serum Alkaline Phosphatase levels on Baseline, Post-operative Day 1 to 7 and 14 |
| Secondary | Time to normalisation of Gamma-Glutamyl Transferase | Post-operative Day 14 | Gamma-Glutamyl Transferase levels on baseline, Post-operative Day 1 to 7 and 14 |
| Secondary | Effect on TNF-alpha (Tumor Necrosis Factor alpha) | Post-operative Day 7 | TNF-alpha (Tumor Necrosis Factor alpha) levels on Baseline, Post-operative Day 3 and 7 |
| Secondary | Effect on IL-6 (Interleukin-6) | Post-operative day 7 | IL-6 levels on baseline , post-operative day 3 and 7 |
| Secondary | Effect on TGF-beta (Transforming Growth Factor beta) | POst-operative Day 7 | TGF-beta levels on Baseline, Post-operative Day 3 and 7 |
| Secondary | Effect on AFP (Alpha-fetoprotein) | Post-operative day 7 | AFP (Alpha-fetoprotein) levels on Baseline, post-operative Day 3 and Day 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07085806/registered